Thyrocare Technologies is a medical diagnostics services provider operating a centralized laboratory model and the largest single-location diagnostics lab in the Asia Pacific region. The company runs a broad network of more than 20,000 service centers across 1,000 cities, over 25,000 sample collection points, and 600 franchisees covering more than 100,000 doctors. Thyrocare processes over 100,000 investigations each night and emphasizes strong logistics and proprietary laboratory automation and IT systems. Its services focus on low-cost, preventive testing with particular leadership in thyroid testing and numerical pathology. The company holds ISO 9001-2000 certification and accreditations from NABL and the College of American Pathologists (CAP). Thyrocare plans to use new capital to fund further expansion and to explore global markets while scaling its in-vitro model globally and in-vivo model nationally.

Total raised

$22M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2012